Zorgvisie
“De Nederlandse Zorgautoriteit (NZa) heeft de bekostiging van farmaceutische telezorg mogelijk gemaakt door deze ‘prestatie’ toe te voegen aan de beleidsregel Extramurale zorg. Zorgaanbieders kunnen voortaan patiënten die thuis wonen op afstand medicijnen aanreiken.
[ More ]
Dr. Malpani's Blog
“In the past, pharmaceutical companies were held in high regard because the drugs they helped to discover saved lives and helped fight diseases. Today, on the other hand, they get lots of bad press.
[ More ]
Katrina Megget, Pharma Times
“The use of real world data will be important in determining access to medicines in the future and the UK should embrace the opportunity of being a world leader in this area, a new report from the country’s pharma trade body says.
[ More ]
Justin Montgomery, mHealthWatch
“Pharmaceutical marketers are building mobile apps at a record pace, especially ones geared towards physicians, but experts warn that a lack of a disciplined strategic approach can lessen the chance of success.
[ More ]
Pamela Lewis Dolan, amednews
“Some pharmaceutical companies shut down Facebook pages, while others monitored and deleted visitor comments, after the social media site on Aug. 15 stopped giving drug companies the option of preventing public comments on their pages.
[ More ]
Christian Torres, The Washington Post
“Facebook and the pharmaceutical industry have had an uneasy partnership in recent years. Many drug companies didn’t join the site until Facebook gave them a privilege that others do not have — blocking the public’s ability to openly comment on a page Wall.
[ More ]
Neil Versel, mobihealthnews
“Not only are physicians picking up iPads in astounding numbers, so are pharmaceutical sales representatives. However, the presence of an iPad doesn’t always make for a better detailing session.
[ More ]
Satish Misra, iMedicalApps
“Nearly one month ago, iMedicalApps took a closer look at how pharmaceutical companies were driving production of our favorite apps, including Epocrates. Through services like DocAlert, Virtual Representative, sponsored disease-specific resources, and more, pharmaceutical companies are redirecting their large marketing budgets to the medical app world.
[ More ]
Matthew Arnold, MM&M
“For pharmas and their agencies, it’s what the agency isn’t interested in that’s more significant. Exempted from the draft guidance were mobile apps that are digital versions of medical textbooks or reference materials but do not contain patient-specific info;
[ More ]
Houston Neal, Software Advice
“There’s a lot of talk about the risks of storing health information in electronic medical records (EMRs). But, EMRs aren’t the problem. Those consent forms you sign at the doctor’s office… yeah, you should pay attention to the fine print. You may be giving permission to insurance companies, drug makers, and data aggregators to access your health information, regardless of how or where it’s stored.
[ More ]
Aubrey Westgate, Physicians Practice
“Pharmaceutical companies cheered as the U.S. Supreme Court recently overturned a Vermont law banning data mining for prescription drug marketing purposes. Many physicians, however, did not share similar celebratory feelings.
[ More ]
Lauren DeLisa Coleman, Business Insider
“Google may have just killed off one of its most ambitious projects to date, Google Health (which essentially sought to remake healthcare delivery for the Web age); but this action is far from indicative of a quiet but growing bold, new digital transformation-of-sorts taking place within the healthcare industry.
[ More ]
Woodward C. CMAJ, 183(6)
Hippocrates’ ancient oath to keep secrets sacred between physician and patient is having a rough time of it in the modern age as drug companies, governments and insurers dip into databases rich with personal medical information.
Just how accessible these records should be is a question coming before the United States Supreme Court.
[ More ]
Jennifer Corbett Dooren, Wall Street Journal
“Pfizer Inc. is conducting a drug trial in which patients participate from their homes using computers and smartphones rather than visiting a clinic.
[ More ]
Hal Amens, EHR Bloggers
“Traditional pharmaceutical research for regulatory approval looks like this:
Test panel -> Test -> Analyze -> Yes or No
This is a limited test to support approval of a new medication based on demonstrated safety and effectiveness. It supports a yes or no by the Food and Drug Administration based on the evidence that can be derived from a relatively small sized sample.
[ More ]
Simon Letellier, Informatique Médicale,TIC & Pharmacie
“Dans sa délibération du 6 mai 2010, la Commission nationale de l’informatique et des libertés (CNIL) a autorisé, à titre expérimental, l’utilisation du Dossier Pharmaceutique dans les pharmacies hospitalières (ou pharmacies à usage intérieur – PUI).
[ More ]
Andrew Tolve, eyeforpharma
“Pharma has proved eager to take its tablets, using the iPad similar devices to sharpen sales and marketing efforts. (For more on pharma’s use of the iPad, see ‘Will the iPad kickstart a pharma sales and marketing revolution?’.)
Now, the industry will have even more tablets, with more functionality, from which to choose.
[ More ]
GLG Expert Contributor
“To stall the change from ICD-9 to ICD-10, very year we hear of health care provider advocates which have raised concerns in part of lost time from retraining staff; and significant added financial burden created by administrative changes due to the added complexity of ICD-10– all accurate, and thus far, successful in holding off the change.
[ More ]
Hal Amens, EHR Bloggers
“Pharmaceutical litigation is where huge lawsuits are common. I predict that this will change and the change will reduce the damage to the bodies and lives of patients, reduce the cost of healthcare, and speed up the process of moving new medications from the laboratory to patients. What will cause that change?
[ More ]
Matthew Herper, Forbes
“Twenty-two years ago Francis Collins, who would go on to head the Human Genome Project and run the National Institutes of Health, was part of a team that found the gene that, when mutated, caused cystic fibrosis, a deadly childhood disease in which the lungs fill with mucus and the pancreas does not make digestive enzymes.
[ More ]
